ADAMTS13 and COVID-19: The implications of low ADAMTS13 activity in COVID-19 have also been shown in pregnancy, with an increased vWF RiCof:ADAMTS13 activity ratio being significantly associated with a higher risk of pregnancy-related complications including pre-term delivery (OR 1.9, 95% CI 1.1–3.5).